申请人:Walji Abbas M
公开号:US20130059850A1
公开(公告)日:2013-03-07
The present invention is directed to certain Aza-Indole derivatives which are useful as modulators of Fatty Acid Amide Hydrolase (FAAH) and as FAAH imaging agents. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer Disease, and Parkinson's Disease.
本发明涉及某些Aza-Indole衍生物,其可用作脂肪酸酰胺水解酶(FAAH)的调节剂和FAAH成像剂。本发明还涉及包含这些化合物作为活性成分的制药配方,以及这些化合物和它们的配方在治疗某些疾病中的使用,包括骨关节炎、类风湿性关节炎、糖尿病神经病变、带状疱疹后神经痛、骨骼肌疼痛和纤维肌痛,以及急性疼痛、偏头痛、睡眠障碍、阿尔茨海默病和帕金森病。